Guanosine 5'-O-(3-thiotriphosphate) tetralithium salt is a non-hydrolyzable analog of GTP known to activate GTP-binding proteins that are crucial for vesicle formation processes that SEC16 proteins coordinate. Adenosine 5'-Triphosphate, disodium salt serves as a non-hydrolyzable ATP analog, potentially activating ATPases which might interact with or modulate SEC16L function, suggesting an indirect route to enhancing the protein's activity in the cell. Epidermal Growth Factor (EGF) is another example; it binds to its receptor and initiates a signaling cascade, particularly the MAPK/ERK pathway, which is known to influence various cellular processes including vesicle trafficking. This pathway can have downstream effects on proteins like SEC16L by modifying the cellular environment in which they operate. Brefeldin A, on the other hand, disrupts the structure and function of the Golgi apparatus, which could lead to a compensatory increase in ER-to-Golgi trafficking, potentially involving SEC16L in the process.
The cAMP analog 8-Br-cAMP activates protein kinase A (PKA), which can lead to the phosphorylation of proteins that might interact with or modulate SEC16L's role in vesicle trafficking. Meanwhile, compounds such as Ionomycin and Thapsigargin alter calcium homeostasis within the cell, impacting calcium-dependent kinases and phosphatases that may modulate SEC16L activity. Through such modulation, these activators indirectly influence the function of SEC16L in vesicle formation and trafficking. Microtubule dynamics, essential for intracellular transport, can be affected by agents like Nocodazole, which destabilizes microtubules, and Taxol, which stabilizes them. These agents could consequently impact the microtubule-dependent trafficking processes that SEC16L may be associated with. Monensin is an ionophore that disrupts intracellular transport and could lead to alterations in cellular trafficking systems, potentially increasing SEC16L activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $456.00 | ||
Non-hydrolyzable GTP analog, can activate GTPases involved in vesicle formation, possibly affecting SEC16L's role in vesicle budding. | ||||||
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $38.00 $74.00 | 9 | |
Non-hydrolyzable ATP analog, can activate ATPases that might interact with or modulate the function of SEC16L. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts Golgi structure and function, leading to a compensatory upregulation of ER-Golgi traffic which might enhance SEC16L activity. | ||||||
Angiotensin II [Sar1 Ile8] | 67724-27-0 | sc-391239 sc-391239A | 5 mg 10 mg | $151.00 $215.00 | ||
Hypothetical activators that would directly activate Sar1p, a GTPase that recruits SEC16 to ER exit sites. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
cAMP analog that activates PKA, potentially influencing phosphorylation of proteins that interact with or modulate SEC16L. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $134.00 $502.00 | 7 | |
Cdc42 inhibitor, altering actin dynamics which can potentially affect SEC16L-related vesicle formation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium, affecting calcium-dependent kinases and phosphatases that may modulate SEC16L activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which can lead to a stress response affecting SEC16L activity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Destabilizes microtubules, potentially impacting microtubule-dependent trafficking and indirectly influencing SEC16L function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Stabilizes microtubules, potentially affecting microtubule-based transport and SEC16L function. | ||||||